Lumbosacral dorsopathies: modern aspects of diagnosis and pharmacological treatment

Abstract

Lumbosacral dorsopathy is the most common diagnosis in patients with lower back pain. Issues of conservative treatment of lumbosacral dorsopathies are considered based on the analysis of scientific materials contained in large databases such as PubMed, Cochrane library, MEDLINE, and eLibrary. From all publications, 40 of the most relevant works were selected and considered in detail, and key figures and short conclusions for each work are displayed in a table. Symptoms of lumbosacral dorsopathies often have an extremely negative effect on the patient’s ability to work and quality of life; therefore, effective and prompt treatment is important. Given the complex and multifactorial pathogenesis and multitudes of options for lumbosacral dorsopathies, conservative treatment should be complex and individualized, and drugs should have a high safety profile, especially those used in the treatment of chronic diseases. These requirements are met by some nonsteroidal anti-inflammatory drugs and co-analgesics, such as chondroprotectors and B vitamins. For the treatment of acute and exacerbated lumbosacral dorsopathies, the local use of hormonal drugs, anticonvulsants, antidepressants, muscle relaxants, etc., is possible, while treatment dosage and duration should be strictly limited. The local use of hormonal drugs and hodroprotectors such as therapeutic and diagnostic blockades is justified in the absence of contraindications and availability of opportunities, which helps reduce the likelihood of systemic adverse reactions and provides greater bioavailability.

Keywords

dorsopathy / back pain / chondroprotectors / nonsteroidal anti-inflammatory drugs / B vitamins / antidepressants / muscle relaxants / anticonvulsants

References

[1] Levin OS. Vertebrogenic lumbosacral radiculopathy: modern approaches to diagnostics and treatment. Ehffektivnaya farmakoterapiya. 2015;(23):40–49. (In Russ.).

[2] Левин О.С. Вертеброгенная пояснично-крестцовая радикулопатия:современные подходы к диагностике и лечению // Эффективная фармакотерапия. 2015. № 23. С. 40–49.

[3] Odinak MM, Zhivolupov SA. Zabolevaniya i travmy perifericheskoi nervnoi sistemy. Saint-Petersburg: SpetsLit, 2009. 384 p. (In Russ.).

[4] Одинак М.М., Живолупов С.А. Заболевания и травмы периферической нервной системы. Санкт-Петербург: СпецЛит, 2009. 384 с.

[5] Parfenov VA, Yakhno NN, Kukushkin ML, et al. Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2018;10:4–11. (In Russ.). DOI: 10.30629/2658-7947-2019-2-5-14-20

[6] Парфенов В.А., Яхно Н.Н., Кукушкин М.Л., и др. Острая неспецифическая (скелетно-мышечная) поясничная боль. Рекомендации Российского общества по изучению боли (РОИБ) // Неврология, нейропсихиатрия, психосоматика. 2018. Т. 10, № 2. С. 4–11. DOI: 10.30629/2658-7947-2019-2-5-14-20

[7] Samartsev IN, Zhivolupov SA, Nazhmudinov RZ, Yakovlev YeV. Study CAMELLIA: Comparative Evaluation of Safety and Efficacy of Aceclofenac and Meloxicam Short–Term Use in Patients with Vertebrogenic Dorsalgia. Ehffektivnaya farmakoterapiya. Nevrologiya. 2018;(3):38–49. (In Russ.). DOI: 10.32863/1682-7392-2018-3-63-36-38

[8] Самарцев И.Н., Живолупов С.А., Нажмудинов Р.З., Яковлев Е.В. Исследование КАМЕЛИЯ: сравнительная оценка безопасности и эффективности кратковременного применения ацеклофенака и мелоксикама у пациентов с вертеброгенными дорсалгиями // Эффективная фармакотерапия. Неврология. 2018. № 3. С. 38–49. DOI: 10.32863/1682-7392-2018-3-63-36-38

[9] Titova NV. Patsient s nespetsificheskoi bol'yu v nizhnei chasti spiny: algoritm diagnostiki i terapii. Russkii meditsinskii zhurnal. Meditsinskoe obozrenie. 2016;24(12):775–781. (In Russ.).

[10] Титова Н.В. Пациент с неспецифической болью в нижней части спины: алгоритм диагностики и терапии // Русский медицинский журнал. Медицинское обозрение. 2016. Т. 24, № 12. С. 775–781.

[11] Backonja M, Williams L, Miao X, et al. Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial). Pain. 2017;158(9):1802–1812. DOI:10.1097/j.pain.0000000000000983

[12] Backonja M., Williams L., Miao X., et al. Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial) // Pain. 2017. Vol. 158. No. 9. P. 1802–1812. DOI:10.1097/j.pain.0000000000000983

[13] Lin JH, Chiang YH, Chen CC. Lumbar radiculopathy and its neurobiological basis. World J Anesthesiol. 2014;3(2):162–173. DOI: 10.5313/wja.v3.i2.162

[14] Lin J.H., Chiang Y.H., Chen C.C. Lumbar radiculopathy and its neurobiological basis // World J Anesthesiol. 2014. Vol. 3. No. 2. P. 162–173. DOI: 10.5313/wja.v3.i2.162

[15] Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica. Cochrane Database Syst Rev. 2010;(6):CD007612. DOI: 10.1002/14651858.CD007612.pub2

[16] Dahm K.T., Brurberg K.G., Jamtvedt G., Hagen K.B. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica // Cochrane Database Syst Rev. 2010. Vol. 6. ID CD007612. DOI: 10.1002/14651858.CD007612.pub2

[17] Hinz B, Renner B, Brune K. Drug insight: cyclo-oxygenase-2 inhibitors-a critical appraisal. Nat Clin Pract Rheumatol. 2007;3(10):552–589. DOI: 10.1038/ncprheum0619

[18] Hinz B., Renner B., Brune K. Drug insight: cyclo-oxygenase-2 inhibitors-a critical appraisal // Nat Clin Pract Rheumatol. 2007. Vol. 3. No. 10. P. 552–589. DOI: 10.1038/ncprheum0619

[19] 10. Hunter TS, Robison C, Gerbino PP. Emerging evidence in NSAID pharmacology: important considerations for product selection. Am J Manag Care. 2015;21(7):139–147.

[20] Hunter T.S., Robison C., Gerbino P.P. Emerging evidence in NSAID pharmacology: important considerations for product selection // Am J Manag Care. 2015. Vol. 21. No. 7. P. 139–147.

[21] Miki K, Ikemoto T, Hayashi K, et al. Randomized open-label [corrected] non–inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain. J Orthop Sci. 2018;23(3):483–487. Corrected and republished from: J Orthop Sci. 2019;24(1):192. DOI: 10.1016/j.jos.2018.02.007

[22] Miki K., Ikemoto T., Hayashi K., et al. Randomized open-label [corrected] non–inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain // J Orthop Sci. 2018. Vol. 23. No. 3. P. 483–487. Corrected and republished from: J Orthop Sci. 2019. Vol. 24. No. 1. P. 192. DOI: 10.1016/j.jos.2018.02.007

[23] Plapler PG, Scheinberg MA, Ecclissato Cda C, et al. Double–blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain. Drug Des Devel Ther. 2016;10:1987–1993. DOI: 10.2147/DDDT.S97756

[24] Plapler P.G., Scheinberg M.A, Ecclissato Cda C., et al. Double–blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain // Drug Des Devel Ther. 2016. Vol. 10. P. 1987–1993. DOI: 10.2147/DDDT.S97756

[25] Schwartz JI, Dallob AL, Larson PJ, et al. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. J Clin Pharmacol. 2008;48(6):745–754. DOI: 10.1177/0091270008317590

[26] Schwartz J.I., Dallob A.L., Larson P.J., et al. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects // J Clin Pharmacol. 2008. Vol. 48. No. 6. P. 745–754. DOI: 10.1177/0091270008317590

[27] Shin JS, Ha IH, Lee J, et al. Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: a multicenter, randomized, controlled, comparative effectiveness trial. Pain. 2013;154(7):1030–1037. DOI: 10.1016/j.pain.2013.03.013

[28] Shin J.S., Ha I.H., Lee J., et al. Effects of motion style acupuncture treatment in acute low back pain patients with severe disability: a multicenter, randomized, controlled, comparative effectiveness trial // Pain. 2013. Vol. 154. No. 7. P. 1030–1037. DOI: 10.1016/j.pain.2013.03.013

[29] von Heymann WJ, Schloemer P, Timm J, Muehlbauer B. Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo. Spine. 2013;38(7):540–548. DOI: 10.1097/BRS.0b013e318275d09c

[30] von Heymann W.J., Schloemer P., Timm J., Muehlbauer B. Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo // Spine (Phila Pa 1976). 2013. Vol. 38. No. 7. P. 540–548. DOI: 10.1097/BRS.0b013e318275d09c

[31] Williams CM, Maher CG, Latimer J, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384(9954):1586–1596. DOI: 10.1016/S0140-6736(14)60805-9

[32] Williams C.M., Maher C.G., Latimer J., et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial // Lancet. 2014. Vol. 384. No. 9954. P. 1586–1596. DOI: 10.1016/S0140-6736(14)60805-9

[33] Ximenes A, Robles M, Sands G, Vinueza R. Valdecoxib is as efficacious as diclofenac in the treatment of acute low back pain. Clin J Pain. 2007;23(3):244–250. DOI: 10.1097/AJP.0b013e31802f67c6

[34] Ximenes A., Robles M., Sands G., Vinueza R. Valdecoxib is as efficacious as diclofenac in the treatment of acute low back pain // Clin J Pain. 2007. Vol. 23. No. 3. P. 244–250. DOI: 10.1097/AJP.0b013e31802f67c6

[35] Cloutier C, Taliano J, O'Mahony W, et al. Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study. Pain Res Manag. 2013;18(2):75–82. Corrected and republished from: Pain Res Manag. 2013;18(6):328. DOI: 10.1155/2013/164609

[36] Cloutier C., Taliano J., O'Mahony W., et al. Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study // Pain Res Manag. 2013. Vol. 18. No. 2. P. 75–82. Corrected and republished from: Pain Res Manag. 2013. Vol. 18. No. 6. ID 328. DOI: 10.1155/2013/164609

[37] Lee JH, Lee CS, Ultracet ER Study Group. A randomized, double- blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. Clin Ther. 2013;35(11):1830–1840. DOI: 10.1016/j.clinthera.2013.09.017

[38] Lee J.H., Lee C.S., Ultracet ER Study Group. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended- release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain // Clin Ther. 2013. Vol. 35. No. 11. P. 1830–1840. DOI: 10.1016/j.clinthera.2013.09.017

[39] Rauck RL, Bookbinder SA, Bunker TR, et al. A randomized, open- label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag. 2006;2(6):325–333. DOI: 10.5055/jom.2006.0048

[40] Rauck R.L., Bookbinder S.A., Bunker T.R., et al. A randomized, open- label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial // J Opioid Manag. 2006. Vol. 2. No. 6. P. 325–333. DOI: 10.5055/jom.2006.0048

[41] Schiphorst Preuper HR, Geertzen JH, van Wijhe M, et al. Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT. Eur Spine J. 2014;23(4): 800–806. DOI: 10.1007/s00586-014-3229-7

[42] Schiphorst Preuper H.R., Geertzen J.H., van Wijhe M., et al. Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT // Eur Spine J. 2014. Vol. 23. No. 4. P. 800–806. DOI: 10.1007/s00586-014-3229-7

[43] Ivanova MA, Parfenov VA, Isaikin AI. Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):59–65. (In Russ.). DOI: 10.14412/2074-2711-2018-3-59-65

[44] Иванова М.А., Парфенов В.А., Исайкин А.И. Консервативное лечение пациентов с дискогенной пояснично-крестцовой радикулопатией (результаты проспективного наблюдения) // Неврология, нейропсихиатрия, психосоматика. 2018. Т. 10, № 3. С. 59–65. DOI: 10.14412/2074-2711-2018-3-59-65

[45] Cohen SP, Hanling S, Bicket MC, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. Br Med J. 2015;350:h1748. DOI: 10.1136/bmj.h1748

[46] Cohen S.P., Hanling S., Bicket M.C., et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study // Br Med J. 2015. Vol. 350. ID h1748. DOI: 10.1136/bmj.h1748

[47] Kennedy DJ, Zheng PZ, Smuck M, et al. A minimum of 5-year follow-up after lumbar transforaminal epidural steroid injections in patients with lumbar radicular pain due to intervertebral disc herniation. Spine J. 2018;18(1):29–35. DOI: 10.1016/j.spinee.2017.08.264

[48] Kennedy D.J., Zheng P.Z., Smuck M., et al. A minimum of 5-year follow-up after lumbar transforaminal epidural steroid injections in patients with lumbar radicular pain due to intervertebral disc herniation // Spine J. 2018. Vol. 18. No. 1. P. 29–35. DOI: 10.1016/j.spinee.2017.08.264

[49] Eskin B, Shih RD, Fiesseler FW, et al. Prednisone for emergency department low back pain: a randomized controlled trial. J Emerg Med. 2014;47(1):65–70. DOI: 10.1016/j.jemermed.2014.02.010

[50] Eskin B., Shih R.D., Fiesseler F.W., et al. Prednisone for emergency department low back pain: a randomized controlled trial // J Emerg Med. 2014. Vol. 47. No. 1. P. 65–70. DOI: 10.1016/j.jemermed.2014.02.010

[51] Goldberg H, Firtch W, Tyburski M, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA. 2015;313(19):1915–1923. DOI: 10.1001/jama.2015.4468

[52] Goldberg H., Firtch W., Tyburski M., et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial // JAMA. 2015. Vol. 313. No. 19. P. 1915–1923. DOI: 10.1001/jama.2015.4468

[53] Manchikanti L, Singh V, Cash KA, et al. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: a randomized, controlled, double blind trial with a two-year follow-up. Pain Physician. 2012;15(4):273–286. DOI: 10.36076/ppj.2012/15/273

[54] Manchikanti L., Singh V., Cash K.A., et al. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: a randomized, controlled, double blind trial with a two-year follow-up // Pain Physician. 2012. Vol. 15. No. 4. P. 273–286. DOI: 10.36076/ppj.2012/15/273

[55] Park CH, Lee SH, Park HS. Lumbar retrodiscal versus post-ganglionic transforaminal epidural steroid injection for the treatment of lumbar intervertebral disc herniations. Pain Physician. 2011;14(4):353–360. DOI: 10.36076/ppj.2011/14/353

[56] Park C.H., Lee S.H., Park H.S. Lumbar retrodiscal versus post-ganglionic transforaminal epidural steroid injection for the treatment of lumbar intervertebral disc herniations // Pain Physician. 2011. Vol. 14. No. 4. P. 353–360. DOI: 10.36076/ppj.2011/14/353

[57] Singh JR, Cardozo E, Christolias GC. The Clinical Efficacy for Two-Level Transforaminal Epidural Steroid Injections. PM and R. 2017;9(4):377–382. DOI: 10.1016/j.pmrj.2016.08.030

[58] Singh J.R., Cardozo E., Christolias G.C. The Clinical Efficacy for Two-Level Transforaminal Epidural Steroid Injections // PM and R. 2017. Vol. 9. No. 4. P. 377–382. DOI: 10.1016/j.pmrj.2016.08.030

[59] Baron R, Martin-Mola E, Müller M, et al. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study. Pain Pract. 2015;15(5):455–470. DOI: 10.1111/papr.12200

[60] Baron R., Martin-Mola E., Müller M., et al. Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study // Pain Pract. 2015. Vol. 15. No. 5. P. 455–470. DOI: 10.1111/papr.12200

[61] Baron R, Freynhagen R, Tölle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150(3):420–427. DOI: 10.1016/j.pain.2010.04.013

[62] Baron R., Freynhagen R., Tölle T.R., et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy // Pain. 2010. Vol. 150. No. 3. P. 420–427. DOI: 10.1016/j.pain.2010.04.013

[63] 32. Kalita J, Kohat AK, Misra UK, Bhoi SK. An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache. J Neurol Sci. 2014;342(1-2):127–132. DOI: 10.1016/j.jns.2014.05.002

[64] Kalita J., Kohat A.K., Misra U.K., Bhoi S.K. An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache // J Neurol Sci. 2014. Vol. 342. No. 1-2. P. 127–132. DOI: 10.1016/j.jns.2014.05.002

[65] Markman JD, Frazer ME, Rast SA, et al. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 2015;84(3):265–272. DOI: 10.1212/WNL.0000000000001168

[66] Markman J.D., Frazer M.E., Rast S.A., et al. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication // Neurology. 2015. Vol. 84. No. 3. P. 265–272. DOI: 10.1212/WNL.0000000000001168

[67] Br Brötz D, Maschke E, Burkard S, et al. Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica? Pain. 2010;149(3):470–475. DOI: 10.1016/j.pain.2010.02.015

[68] Br Brötz D., Maschke E., Burkard S., et al. Is there a role for benzodiazepines in the management of lumbar disc prolapse with acute sciatica? // Pain. 2010. Vol. 149. No. 3. P. 470–475. DOI: 10.1016/j.pain.2010.02.015

[69] Friedman BW, Cisewski D, Irizarry E, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain. Ann Emerg Med. 2018;71(3):348–356.e5. DOI: 10.1016/j.annemergmed.2017.09.031

[70] Friedman B.W., Cisewski D., Irizarry E., et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain // Ann Emerg Med. 2018. Vol. 71. No. 3. P. 348–356.e5. DOI: 10.1016/j.annemergmed.2017.09.031

[71] Danilov AB. Lechenie ostroi boli v spine: vitaminy gruppy «В» ili NPVP? Russian Medical Journal. 2010;(0):35–43. (In Russ.).

[72] Данилов А.Б. Лечение острой боли в спине: витамины группы «В» или НПВП? // Русский медицинский журнал. 2010. № 0. С. 35–43.

[73] Chiu CK, Low TH, Tey YS, et al. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J. 2011;52(12):868–873.

[74] Chiu C.K., Low T.H., Tey Y.S., et al. The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial // Singapore Med J. 2011. Vol. 52. No. 12. P. 868–873.

[75] 38. Mibielli MA, Geller M, Cohen JC, et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin. 2009;25(11):2589–2599. DOI: 10.3111/13696990903246911

[76] Mibielli M.A., Geller M., Cohen J.C., et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study // Curr Med Res Opin. 2009. Vol. 25. No. 11. P. 2589–2599. DOI: 10.3111/13696990903246911

[77] Barulin AE, Kurushina OV. Chondroprotectors in сomplex treatment for back pain. Difficult Patient. 2014;12(3):35–38. (In Russ.).

[78] Барулин А.Е., Курушина О.В. Хондропротекторы в комплексной терапии болей в спине // Трудный пациент. 2014. Т. 12, № 3. С. 35–38.

[79] Belyaev RA. Ehffektivnost' khondroprotektornoi terapii vertebrogennykh dorsopatii. Vestnik KazNMU. 2010;(3):135–139. (In Russ.).

[80] Беляев Р.А. Эффективность хондропротекторной терапии вертеброгенных дорсопатий // Вестник КазНМУ. 2010. № 3. С. 135–139.

[81] Danilov AB, Zharkova TR, Akhmetdzhanova LT. Anal'geticheskie svoistva preparata Alflutop v lechenii khronicheskoi boli v spine. Prilozhenie k zhurnalu Consilium medicum. 2010;(2):56–59. (In Russ.).

[82] Данилов А.Б., Жаркова Т.Р., Ахметджанова Л.Т. Анальгетические свойства препарата Алфлутоп в лечении хронической боли в спине // Неврология и ревматология. Приложение к журналу Consilium medicum. 2010. № 2. С. 56–59.

[83] Kaishibayeva G. Effectiveness of the drug Alflutop in patients with vertebral pathology. Herald of Almaty State Institute of Advanced Medical Education. 2012;(4):59–62. (In Russ.).

[84] Кайшибаева Г.С. Эффективность препарата Алфлутоп у пациентов с вертеброгенной патологией // Вестник АГИУВ. 2012. № 4. С. 59–62.

[85] Koval'chuk VV. Primenenie preparata Alflutop kak vozmozhnost' povysheniya ehffektivnosti traditsionnoi terapii bol'nykh, stradayushchikh bolyami v spine. Russian Medical Journal. 2014;22(10):777–781. (In Russ.).

[86] Ковальчук В.В. Применение препарата Алфлутоп как возможность повышения эффективности традиционной терапии больных, страдающих болями в спине // Русский медицинский журнал. 2014. Т. 22, № 10. С. 777–781.

[87] Kurganova YuM, Danilov AB. Melatonin in the treatment of low back pain and predictors of its efficacy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10):49–54. (In Russ.). DOI: 10.17116/jnevro201711710149-54

[88] Курганова Ю.М., Данилов А.Б. Мелатонин при боли в спине и предикторы его эффективности // Журнал неврологии и психиатрии им. С.С. Корсакова. 2017. № 10. С. 49–54. DOI: 10.17116/jnevro201711710149-54

[89] Morozova OH, Yaroshevskyi OA, Lipinska YV. The effectiveness of Arthrida® in lower back pain. International Neurological Journal. 2018;(6):37–43. (In Russ.).

[90] Морозова О.Г., Ярошевский А.А., Липинская Я.В. Эффективность препарата Артрида® при боли в нижней части спины // Международный неврологический журнал. 2018. № 6. С. 37–43.

[91] Yaroshevskiy AA. Analysis of the use of chondroprotectors in complex therapy of vertebrogenic dorsalgia. International Neurological Journal. 2014;(1):75–81. (In Russ.). DOI: 10.22141/2224-0713.1.63.2014.80447

[92] Ярошевский А.А. Анализ использования хондропротекторов в комплексной терапии вертеброгенной дорсалгии // Международный неврологический журнал. 2014. № 1. С. 75–81. DOI: 10.22141/2224-0713.1.63.2014.80447

[93] Farajirad S, Behdani F, Hebrani P, Farajirad M. Comparison Between the Effects of Amitriptyline and Bupropione on the Quality of Life and the Reduction in the Severity of Pain in Patients With Chronic Low-Back Pain. Neurosurgery Quarterly. 2013;23(4):227–229. DOI: 10.1097/WNQ.0b013e3182817d55

[94] Farajirad S., Behdani F., Hebrani P., Farajirad M. Comparison Between the Effects of Amitriptyline and Bupropione on the Quality of Life and the Reduction in the Severity of Pain in Patients With Chronic Low-Back Pain // Neurosurgery Quarterly. 2013. Vol. 23. No. 4. P. 227–229. DOI: 10.1097/WNQ.0b013e3182817d55

[95] Mazza M, Mazza O, Pazzaglia C, et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother. 2010;11(7):1049–1052. DOI: 10.1517/14656561003730413

[96] Mazza M., Mazza O., Pazzaglia C., et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain // Expert Opin Pharmacother. 2010. Vol. 11. No. 7. P. 1049–1052. DOI: 10.1517/14656561003730413

[97] Skljarevski V, Zhang S, Desaiah D, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain. 2010;11(12):1282–1290. DOI: 10.1016/j.jpain.2010.03.002

[98] Skljarevski V., Zhang S., Desaiah D., et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial // J Pain. 2010. Vol. 11. No. 12. P. 1282–1290. DOI: 10.1016/j.jpain.2010.03.002

RIGHTS & PERMISSIONS

Zhivolupov S.A., Kozhevnikov E.Y., Samartsev I.N., Rashidov N.A.